Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Pharmacokinetics

Interventions

DRUG

AZD8566

10ml oral solution administered once a day over 10 days. Specific dose will be selected by the safety review committee

DRUG

Placebo

10ml oral solution administered once a day over 10 days.

Trial Locations (1)

Research Site, Macclesfield